Title Canadian CML registry
Protocole ID Registre LMC
ClinicalTrials.gov ID
Cancer Type(s) Chronic Myeloid Leukemia
Phase
Stage
Study Type
Drug
Institution CHU DE QUEBEC – UNIVERSITE LAVAL
   L'HOTEL-DIEU DE QUEBEC ET CRCEO
      11 Côte du Palais, Québec, QC, G1R 2J6
City Québec
Principal Investigator Dr. Marc Lalancette
Coordinator Diane Bernard
418-525-4444 poste 15782

Patricia Chabot
418-525-4444 poste 15769
Status Recruiting
Activation Date
Eligibility Criteria
Exclusion Criteria